A qualitative gas chromatographic analysis of trimethylsilylated ethyl acetate extracts of melanotic urine revealed 5 indolic compounds, which have been identified as substituted 5,6-dihydroxyindoles. Ethyl acetate extracts of melanotic urines at pH 2.0 contained isomeric 5-hydroxy-6-methoxy and 6-hydroxy-5-methoxy-indolyl-2-carboxylic acids which were not separable under the conditions used. A careful hydrolysis of melanotic urine with a Helix pomatia preparation followed by extraction at pH 6.5 in a nitrogen atmosphere released 3 additional indolic compounds from their conjugated form. Using gas chromatographic-mass spectrometric analysis they were identified as 5-hydroxy-6-methoxy, 6-hydroxy-5-methoxyindole and 5,6-dihydroxyindole.
Get full access to this article
View all access options for this article.
References
1.
AgrupG., AgrupP., AnderssonT., HafströmL., HanssonC., JacobssonS., JönssonP.E., RorsmanH., RosengrenA.M., RosengrenE.: 5 Years experience of 5-S-cysteinyldopa in melanoma diagnosis.Acta Derm.-Venerol., 59: 381–388, 1979.
2.
AllenG.R.Jr., PolettoT., WeissM.J.: The mitomycin antibiotics.Synthetic studies V. - 1. Preparation of 7-methoxymitosene. J. Org. Chem., 30: 2897–2904, 1965.
3.
BandaP.W., SherryA.E., BloisM.S.: Column cation-exchange separation of melanin-related metabolites in urine from cases of melanoma.Clin. Chem., 23: 1397–1411, 1977.
4.
BloisM.S., BandaP.W.: Detection of occult metastatic melanoma by urine chromatography.Cancer Res., 36: 3317–3323, 1976.
5.
DuchonJ., MatousB.: Identification of two new metabolites in melanoma urine: 5-hydroxy-6-me-thoxyindol-2-carboxylic and 6-hydroxy-5-methoxy-indol-2-carboxylic acids.Clin. Chim. Acta, 16: 397–402, 1967.
6.
DuchonJ.: Biochemistry. In: Symposium: Recent Advances in the Diagnosis and Treatment of Malignant Melanoma, pp. 5–17, VIII Review Meeting W.H.O., Brno, 1977.
HabermanH.F., GanE.V., MenonI.A.: Comparison of various methods for determination of melanogens as a diagnostic test for melanoma. In: Melanomas: Basic Properties and Clinical Behaviour, pp. 297–309, Vol. 2, RileyV. (Ed.), Karger, Basel, 1976.
9.
Harley-MasonJ.: Melanin and its precursors. Part VI. Further synthesis of 5: 6-dihydroxyindole and its derivatives. J. Chem. Soc., 200–203, 1953.
10.
HinterbergerF.L., FreedmanA., BartholomewJ.R.: Precursors of melanin in the blood and urine in malignant melanoma.Clin. Chim. Acta, 39: 395–400, 1972.
11.
ItoS., NicolJ.A.C.: Isolation of oligomers of 5,6-dihydroxyindole-2-carboxylic acid from the eye of the catfish.Biochem. T., 143: 207–217, 1974.
12.
MatoušB., MechlZ., SopkováB., DuchonJ., PavelS., BudešínskáA., KocentA.: The excretion of Thormählen positive melanogens in melanoma patients and its clinical significance.Eur. J. Cancer, 16: 383–388, 1980.
13.
MuskietF.A.J., StratinghC.M., StobG.J., WolthersB.G.: Simultaneous determination of the four major catecholamine metabolites and estimation of a serotonin metabolite in urine by capillary gas chromatography of their tert-butyldimethylsilyl de-ivatives.Clin. Chem., 27: 223–227, 1981.
14.
PavelS., MuskietF.A.J., NagelG.T., SchwippelováZ., DuchonJ.: Identification of two Thormählen positive compounds from melanotic urine by gas chromatography-mass spectrometry.J. Chromatogr., Biomed. Appl., 222: 381–388, 1981.
15.
PavelS., MatoušB., MuskietF.A.J., NagelG.T., DuchonJ.: Conjugates of 5,6-dihydroxyindole in melanotic urine. Submitted for publication.
16.
PiatelliM., MinaleL., ProtaG.: Struttura della betanina.Ann. Chim., 54: 955–962, 1964.
17.
ScottJ.A.: 3,4-Dihydroxyphenylalanine (dopa) excretion in patients with malignant melanoma.Lancet, 2: 861–862, 1962.
18.
VallonJ.J., BadinandA., BichonC.: Isolement chromatographique sur Sephadex G-10 des meta-nephrines et des melanogenes des urines.Clin. Chim. Acta, 36: 397–404, 1972.
19.
VoorhessM.L.: Urinary excretion of dopa and metabolites by patients with melanoma.Cancer, 26: 146–149, 1970.
